Picolinamide derivatives as kinase inhibitors

Details for Australian Patent Application No. 2009289319 (hide)

Owner Novartis AG

Inventors Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele

Agent Davies Collison Cave

Pub. Number AU-B-2009289319

PCT Pub. Number WO2010/026124

Priority 61/093,666 02.09.08 US; 61/225,660 15.07.09 US

Filing date 31 August 2009

Wipo publication date 11 March 2010

Acceptance publication date 27 October 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/026124 Priority application(s): WO2010/026124

27 October 2011 Application Accepted

  Published as AU-B-2009289319

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289322-Viscoelastic system for drift reduction

2009289317-Heterocyclic PIM-kinase inhibitors